Skip to content

Fabian Prospective Assessment of Volume Guarantee (Fabian PaVoG)

Prospective Multicenter Observational Study of the Safety and Performance of Fabian Ventilator System Volume Guarantee Mode in Routine Use

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05229172
Acronym
PaVoG
Enrollment
76
Registered
2022-02-08
Start date
2022-02-24
Completion date
2023-06-27
Last updated
2023-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Insufficiency in Children

Brief summary

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product and will provide performance data on the Volume Guarantee function of the fabian ventilator in daily clinical routine.

Detailed description

PaVoG study is a prospective, multicenter, single-cohort post market observational study. The study procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device. To allow data collection, an Informed Consent Form will be obtained from each study participant/ legally authorized representative, if required by the local Ethical Committee. Ventilator data will be recorded in the hospital's data capture system or on a study laptop provided by the Sponsor. Each patient will be clinically evaluated according to hospital standard of care. If inclusion and exclusion criteria are met, and the investigative team is available the patient will be enrolled. Study duration for an individual patient will differ, depending on the time spent on fabian ventilator with Volume Guarantee mode on. It is anticipated that for most will be between 2-4 days.

Interventions

There is no study specific intervention planned. Procedures will be conducted according to standard of care of each participating hospital and the instructions for use of the study device.

Sponsors

Vyaire Medical
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patient ventilated with fabian ventilator (conventional or HFOV) with VG mode active. * The anticipated use of VG mode is at least 12 hours * Informed Consent given by parents or guardians according to the process approved by the local research ethical committee

Exclusion criteria

* Patients with severe airflow obstruction and intracranial hypertension * Decision documented to give palliative neonatal care. * The clinical care team does not agree with inclusion of the infant to the study

Design outcomes

Primary

MeasureTime frameDescription
In Conventional Mechanical Ventilation (CMV) with Volume Guarantee (VG) - Relationship between tidal volume set vs tidal volume observed (Volume guarantee mode)through study completion, an average of 2 - 4 daysDifference between set and observed expired tidal volume (VTe), average - on the patient level and breath-to-breath variability will be reported
In High Frequency Oscillatory Ventilation with Volume Guarantee (HFOV-VG)- Relationship between the set and observed tidal volume of oscillations (VThf) during HFOV-VGthrough study completion, an average of 2 - 4 daysDifference between the set and observed VThf (average and variability)

Secondary

MeasureTime frameDescription
Ventilator Performance - Relationship of Peak Inspiratory Pressure (PIP) during Volume Guarantee (VG) ventilation to the set maximum allowed inflating pressure (Pmax)through study completion, an average of 2 - 4 daysMean difference between Pmax and PIP will bereported
Ventilator Performance - Relationship between the set and observed mean airway pressure (MAP) during HFOVthrough study completion, an average of 2 - 4 daysDifference between the set and observed MAP (average and variability)
Ventilator Performance - Relationship between the set and observed Fraction of Inspired Oxygen (FiO2)through study completion, an average of 2 - 4 daysDifference between the set and observed FiO2 (average and variability)
Ventilator Performance - Reason(s) to switch off Volume Guaranteethrough study completion, an average of 2 - 4 daysThe reason for stopping Volume Guarantee will be documented in the case report form
Ventilator Safety - Device failure ratethrough study completion, an average of 2 - 4 daysMalfunction of the investigational device necessitating removal of a neonate to another ventilation mode or ventilator
Ventilator Safety - Descriptive statistical analysis of all ventilator alarm eventsthrough study completion, an average of 2 - 4 daysA summary table presenting number, type and duration of ventilator alarms within study population
Ventilator Safety - Number of study participants with device related adverse eventsthrough study completion, an average of 2 - 4 daysNumber of malfunction of the investigational device leading to potential or actual patient harm
Ventilator Performance - Relationship between the set and observed Positive End-Expiratory Pressure (PEEP) and Continuous Positive Airway Pressure (CPAP)through study completion, an average of 2 - 4 daysDifference between set and observed PEEP (average and variability)
Exploratory analysis - Relationship between expired tidal volume (VTe) or Minute Volume (MV) and end-tidal CO2 (etCO2) or Partial Pressure of Carbon Dioxide (pCO2) or transcutaneous CO2 (tcCO2) in infants of different clinical characteristicsthrough study completion, an average of 2 - 4 daysCorrelation analysis between expired tidal volume and CO2 measurements per patient
Exploratory analysis - Feasibility of volumetric capnographythrough study completion, an average of 2 - 4 daysA summary table presenting duration, accuracy and availability of volumetric capnography data in neonatal patients
Analysis of patient-ventilator interactions - Analysis of number of triggered and backup ventilator inflations per patientthrough study completion, an average of 2 - 4 daysThe impact of set ventilator rate and expiratory time on the number of triggered and backup inflations.
Analysis of patient-ventilator interactions - analysis of Tidal Volume of triggered and back inflationsthrough study completion, an average of 2 - 4 daysTidal volume of triggered and backup ventilator inflations will be analyzed and compared
Analysis of patient-ventilator interactions - Contribution of the infant to the total minute ventilation via spontaneous breathing between ventilator inflations per patientthrough study completion, an average of 2 - 4 daysThe impact of ventilator modes and settings will be analyzed and compared
Analysis of patient-ventilator interactions - Ventilator-patient asynchronies per patientthrough study completion, an average of 2 - 4 daysThe occurrence and frequency of inspiratory hold during time cycled ventilation. The frequency of interrupted expirations. Occurrence and frequency of incomplete expiration during neonatal ventilation. Calculation of asynchrony index per patient and for study population.
Exploratory analysis - Relationship between end-tidal CO2 (etCO2) or transcutaneous CO2 (tcCO2) and Partial Pressure of Carbon Dioxide (pCO2) in blood gases (capillary and arterial) in infants of different clinical characteristicsthrough study completion, an average of 2 - 4 daysCorrelation between average end-tidal CO2 (etCO2)/ transcutaneous CO2 (tcCO2) and blood gas Partial Pressure of Carbon Dioxide (pCO2); Bland-Altman plots
Ventilator Performance - Variability of Peak Inspiratory Pressure (PIP) during Volume Guarantee (VG) ventilationthrough study completion, an average of 2 - 4 daysStandard deviation of PIP will be reported

Countries

Netherlands, Poland, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026